shingles
Apr 25, 2019
GSK to spend $100M; Lilly sell; Sherlock Bio raises $31M; Deerfield, UIC to foster research
GSK to spend USD 100 M to boost its vaccine production Drug maker GlaxoSmithKline has announced to invest USD100 million in its vaccine production site in Montana-one of its nine manufacturing units in the USA. In order to cope with the supply issues GSK faced last year, the company wishes to boost its vaccine p...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
